Researchers assessed the eosinophil levels and lung function of individuals with low FEV1 reversibility to SABA. The study was presented at the 2019 AAAAI Annual Meeting.
In a new study, researchers sought to examine the role of interleukin 13 in airway inflammation in asthma, as well as the effects of tralokinumab on airway eosinophilic infiltration, blood and sputum...
Previous research has indicated that comorbidities contribute to uncontrolled asthma. In a new study, the researchers sought to investigate this relationship further in order to help improve treatment...
In a recent study, researchers explored the benefits of treatment with omalizumab in patients with various phenotypes of asthma, including early onset allergic asthma, hypereosinophilic severe asthma, and...
Two new studies investigated the safety and efficacy of benralizumab in improving symptoms and exacerbation rates of patients with asthma and elevated eosinophil levels.
